Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects

BACKGROUND: A large body of evidence suggests that thyroid hormones (THs) are beneficial for the treatment of cardiovascular disorders. We have shown that 3 days of triiodo-L-thyronine (T3) treatment in myocardial infarction (MI) rats increased left ventricular (LV) contractility and decreased myocy...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Rajagopalan, Viswanathan, Zhang, Youhua, Ojamaa, Kaie, Chen, Yue-feng, Pingitore, Alessandro, Pol, Christine J., Saunders, Debra, Balasubramanian, Krithika, Towner, Rheal A., Gerdes, A. Martin
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2016
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4794221/
https://ncbi.nlm.nih.gov/pubmed/26981865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0151413
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares